Rapid Pathogen Identification to Delivery of Cures Act - Amends the Homeland Security Act of 2002 to require the Secretaries of Homeland Security, Health and Human Services, and Defense to submit a report setting forth a strategy to reduce the time frame from the identification of a pathogen to the development and emergency approval of a safe and effective countermeasure, which should include: (1) technical impediments to reducing this time frame; (2) research, development, and technology needs to address these impediments; (3) existing efforts to address such needs; (4) a proposal to establish a coordinated and integrated Federal program to address such needs; and (5) potential liability concerns stemming from distribution of rapidly developed priority countermeasures.
Allows the Secretary of Homeland Security to contract with any firm or institution to conduct research and analysis needed for this report.
Requires the Secretary of Health and Human Services to establish a system to rapidly: (1) establish clinical research programs to examine the safety and efficacy of treatments for novel, unknown, or bioengineered pathogens; and (2) disseminate results and recommendations to clinicians. Authorizes establishment of a fund to support such clinical research.
Amends the Public Health Service Act to add the Secretary of Homeland Security to the working group on bioterrorism and to require the working group to assist in developing such a strategy.
Requires the Secretaries of Health and Human Services, Defense, and Homeland Security to conduct programs to develop the capability to rapidly identify, develop, produce, and approve countermeasures.